Long
The Sandbox Bottomed Out (280% Target Mapped)

Hello my fellow crypto-trader, let's start by looking at the Sandbox today shall we?
Here we can notice the Adam & Eve bottom formation which can easily lead to higher prices.
This is the exact same chart that most of the altcoins have and thus we are certain that this pattern will be followed with growth.
Other altcoins with the same pattern already broke bullish and many have growng by 50%, 80%, 100%, 200% & more.
You can find the target mapped on the chart.
Namaste.
Here we can notice the Adam & Eve bottom formation which can easily lead to higher prices.
This is the exact same chart that most of the altcoins have and thus we are certain that this pattern will be followed with growth.
Other altcoins with the same pattern already broke bullish and many have growng by 50%, 80%, 100%, 200% & more.
You can find the target mapped on the chart.
Namaste.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.